Elliott, Hannah R.
Burrows, Kimberley
Min, Josine L.
Tillin, Therese
Mason, Dan
Wright, John
Santorelli, Gillian
Davey Smith, George
Lawlor, Deborah A.
Hughes, Alun D.
Chaturvedi, Nishi
Relton, Caroline L.
Funding for this research was provided by:
Medical research council (MC_UU_00011/5, MC_UU_00011/6, MC_UU_00011/1, MC_UU_00011/5, MC_UU_00011/6, MC_UU_00011/1, MC_UU_00011/5, MC_UU_00011/6, MC_UU_00011/1, MC_UU_00011/5, MC_UU_00011/6, MC_UU_00011/1, MC_UU_00011/5, MC_UU_00011/6, MC_UU_00011/1, MC_UU_00011/5, MC_UU_00011/6, MC_UU_00011/1)
British Heart Foundation (CH/F/20/90003)
National Institute for Health Research (NF-0616-10102)
Article History
Received: 8 June 2022
Accepted: 20 September 2022
First Online: 15 October 2022
Declarations
:
: The SABRE study was approved by St Mary's Hospital Research Ethics Committee (07/H0712/109), and all participants provided written informed consent. Ethical approval for the data collection in BiB was granted by Bradford Research Ethics Committee (Ref 07/H1302/112). All participants gave written informed consent.
: Not applicable.
: DAL has received support from Roche Diagnostics and Medtronic Ltd. during the last 10 years for research unrelated to this study. NC serves on and receives remuneration for data monitoring and safety committees of trials sponsored by AstraZeneca. Other authors declare no conflict of interest.